VRNS vs PATH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
VRNS · Varonis Systems$48.80 ▲ 0.14%
PATH · UiPath$13.00 ▼ 0.08%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- VRNS +41.7%
- PATH -8.5%
Head to head
| Metric | VRNS | PATH |
|---|---|---|
| Price | $48.80 | $13.00 |
| Change today | ▲ 0.14% | ▼ 0.08% |
| Market cap | $5.63B | $6.78B |
| Return, 3 months | +15.0% | -16.6% |
| Return, year to date | +48.8% | -20.7% |
| Return, 1 year | +42.9% | -9.1% |
| P/E (TTM) | -37.0 | 19.4 |
| P/B | 13.0 | 3.5 |
| P/E percentile vs own 5y | 46th | 84th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +18.3% | +13.4% |
| Net profit growth (YoY) | -30.7% | +2,178.3% |
| Gross margin | 77.1% | 82.6% |
| Operating margin | -22.0% | 8.9% |
| Net margin | -20.5% | 21.0% |
| Return on equity | -36.0% | 20.0% |
| Analyst target vs. price | +2.7% | +19.6% |
| Analyst buy share | 6% | 14% |
| RSI (14) | 54 | 43 |
| 30-day volatility | 34.0% | 39.4% |
| Max drawdown, 1 year | -68.0% | -51.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PATH is the largest of the group by market value.
- VRNS has returned the most over the past year.
- VRNS carries the lowest trailing P/E.
- VRNS is growing revenue fastest.
- PATH keeps the most profit per dollar of sales.
- VRNS has been the calmest stock over the last 30 days.